A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability

A Randomized, Open Label, Single Subcutaneous Dose, 2x2 Crossover Study to Investigate the Relative Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

A randomized, Open Label, Single Subcutaneous Dose, 2x2 Crossover Study to Investigate the Relative Bioavailability, Safety and Tolerability among Different Eutropin Formulations in Healthy Volunteers

Inclusion Criteria:

• Healthy adults aged 19 to 40years at screening.
• Voluntarily decide to participate and provide written informed consent.
• Able to receive the investigational product (IP) and pre-treatment drugs.
• Wiliing and able to comply with study requirements, including follow-up visits and blood/urine sampling.

Exclusion Criteria:

• History of conditions contraindicating somatropin or pre-treatment drugs.
• Clinically significant medical history.
• Participation in another clinical trial and receipt of an investigational product within 80 days prior to the first IP administration.